Stay updated on Finerenone and Empagliflozin Combination in CKD Clinical Trial
Sign up to get notified when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.

Latest updates to the Finerenone and Empagliflozin Combination in CKD Clinical Trial page
- Check3 days agoChange DetectedThe study record history now shows a new page revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check10 days agoChange DetectedA new revision entry v3.6.2 was added to the study's history, and the older v3.6.0 entry was removed. This reflects an update to the page's versioning logs rather than any change to the study data or user-facing content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThis update shows the study is no longer recruiting and updates the record to version v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.2%

- Check31 days agoChange DetectedA new version (Revision: v3.5.5) was returned on 2026-06-02. It adds sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other related information, along with a QC status indicator and updated navigation items.SummaryDifference0.8%

- Check53 days agoChange DetectedA new revision entry v3.5.4 is added to the record history, replacing the previous v3.5.3. This reflects an updated version of the study record in the history timeline.SummaryDifference0.1%

- Check60 days agoChange DetectedThe References entry was removed from a version in the Study Record History, reducing visibility of sources cited for that version. The rest of the version details remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Finerenone and Empagliflozin Combination in CKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.